South Korea Medication Assisted Therapy (MAT) Market to 2032
Overview
The South Korea Medication Assisted Therapy (MAT) Market is expected to reach a 291.40 by 2032 and is projected to grow at a CAGR of 14.17% from 2025 to 2032.
Revenue, 2024 ()
146.06
Forecast, 2032 ()
291.40
CAGR, 2024 - 2032
14.17%
Report Coverage
South Korea
South Korea Medication Assisted Therapy (MAT) Market 2018-2032
South Korea Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 146.06
- Projected Market Size (2032): 291.40
- CAGR (2025-2032): 14.17%
Key Findings of South Korea Medication Assisted Therapy (MAT) Market
- The South Korea Medication Assisted Therapy (MAT) Market was valued at 146.06 in 2024.
- The South Korea Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 14.17% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 137.32
- The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 16.76% during the forecast period from 2024 to 2032.
South Korea Medication Assisted Therapy (MAT) Market Scope
South Korea Medication Assisted Therapy (MAT) Market Segmentation & Scope
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
South Korea Medication Assisted Therapy (MAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 146.06 |
| Market Value in 2032 | 291.40 |
| CAGR (2025-2032) | 14.17% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Products,Route of Administration,Population Type,End User,Distribution Channel,Drug Type,Dosage Form |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 146.06 in 2024
- Key Country: South Korea, leading in terms of revenue with value of 146.06 in 2024.
Segments and Scope
-
South Korea Medication Assisted Therapy (MAT) Market to 2032, By Type
- Medication is the largest segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 79.09 in the year 2024.
- Medication is the Fastest growing segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 14.93 % in forecast period 2025-2032.
-
South Korea Medication Assisted Therapy (MAT) Market to 2032, By Products
- Buprenorphine and Naloxone is the largest segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 19.50 in the year 2024.
- Buprenorphine and Naloxone is the Fastest growing segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.76 % in forecast period 2025-2032.
-
South Korea Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
- Oral is the largest segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 43.59 in the year 2024.
- Oral is the Fastest growing segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.74 % in forecast period 2025-2032.
-
South Korea Medication Assisted Therapy (MAT) Market to 2032, By Population Type
- Adults is the largest segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 137.32 in the year 2024.
- Adults is the Fastest growing segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 14.28 % in forecast period 2025-2032.
-
South Korea Medication Assisted Therapy (MAT) Market to 2032, By End User
- Rehabilitation Clinics is the largest segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 65.06 in the year 2024.
- Rehabilitation Clinics is the Fastest growing segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.32 % in forecast period 2025-2032.
-
South Korea Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 43.55 in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.76 % in forecast period 2025-2032.
-
South Korea Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
- Generics is the largest segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 73.11 in the year 2024.
- Generics is the Fastest growing segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.08 % in forecast period 2025-2032.
-
South Korea Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
- Immediate Release is the largest segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 47.97 in the year 2024.
- Immediate Release is the Fastest growing segment in South Korea Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.51 % in forecast period 2025-2032.
South Korea Medication Assisted Therapy (MAT) Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Indivior PLC | |||
| Mallinckrodt | |||
| Sun Pharmaceutical Industries Ltd. | |||
| Teva Pharmaceutical Industries Ltd. | |||
South Korea Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032
South Korea Medication Assisted Therapy (MAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Type,Products,Route of Administration,Population Type,End User,Distribution Channel,Drug Type,Dosage Form.
South Korea Medication Assisted Therapy (MAT) Market was valued at USD 146.06(Revenue in ) in 2020.
South Korea Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 14.17% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the South Korea Medication Assisted Therapy (MAT) Market, holding a largest market share of 137.32 in 2024
Coming Soon....
South Korea Medication Assisted Therapy (MAT) Market Scope
South Korea Medication Assisted Therapy (MAT) Market Segmentation & Scope
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Frequently Asked Questions
The South Korea Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Type,Products,Route of Administration,Population Type,End User,Distribution Channel,Drug Type,Dosage Form.
South Korea Medication Assisted Therapy (MAT) Market was valued at USD 146.06(Revenue in ) in 2020.
South Korea Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 14.17% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Medication Assisted Therapy (MAT) Market for final year is USD 291.40 ().
South Korea Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The South Korea Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Type,Products,Route of Administration,Population Type,End User,Distribution Channel,Drug Type,Dosage Form.
South Korea Medication Assisted Therapy (MAT) Market was valued at USD 146.06(Revenue in ) in 2020.
South Korea Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 14.17% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Medication Assisted Therapy (MAT) Market for final year is USD 291.40 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.